SEC 13F Intelligence

Clifford Swan Investment Counsel LLC / PFE

Clifford Swan Investment Counsel LLC’s Pfizer Inc Position

Does Clifford Swan Investment Counsel LLC own Pfizer Inc (PFE)? Yes — 489.3K shares worth $14M (+0.47% of its 13F portfolio) as of Q1 2026, up from 485.6K shares the prior filed quarter.

Position Value
$14M
Q1 2026
Shares
489.3K
% of Portfolio
+0.47%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $20MQ4 ’18Q1 ’19: $19MQ2 ’19: $20MQ3 ’19: $17MQ4 ’19: $18MQ4 ’19Q1 ’20: $15MQ2 ’20: $15MQ3 ’20: $17MQ4 ’20: $16MQ4 ’20Q1 ’21: $17MQ2 ’21: $20MQ3 ’21: $18MQ4 ’21: $25MQ4 ’21Q1 ’22: $22MQ2 ’22: $22MQ3 ’22: $18MQ4 ’22: $21MQ4 ’22Q1 ’23: $16MQ2 ’23: $15MQ3 ’23: $13MQ4 ’23: $12MQ4 ’23Q1 ’24: $14MQ2 ’24: $15MQ3 ’24: $16MQ4 ’24: $16MQ4 ’24Q1 ’25: $15MQ2 ’25: $14MQ3 ’25: $13MQ4 ’25: $12MQ4 ’25Q1 ’26: $14Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026489.3K$14M+0.47%
Q4 2025485.6K$12M+0.40%
Q3 2025502.7K$13M+0.43%
Q2 2025569.2K$14M+0.49%
Q1 2025596.7K$15M+0.56%
Q4 2024601.6K$16M+0.57%
Q3 2024554.3K$16M+0.57%
Q2 2024519.8K$15M+0.54%
Q1 2024516.9K$14M+0.53%
Q4 2023417.1K$12M+0.47%
Q3 2023398.5K$13M+0.55%
Q2 2023397.5K$15M+0.59%
Q1 2023399.5K$16M+0.68%
Q4 2022406.0K$21M+0.91%
Q3 2022406.6K$18M+0.84%
Q2 2022412.7K$22M+0.94%
Q1 2022420.3K$22M+0.81%
Q4 2021419.8K$25M+0.87%
Q3 2021421.2K$18M+0.67%
Q2 2021444.4K$20M+0.76%
Q1 2021470.9K$17M+0.70%
Q4 2020444.0K$16M+0.71%
Q3 2020455.3K$17M+0.80%
Q2 2020459.2K$15M+0.77%
Q1 2020465.2K$15M+0.92%
Q4 2019463.8K$18M+0.88%
Q3 2019464.7K$17M+0.87%
Q2 2019453.4K$20M+1.03%
Q1 2019457.3K$19M+1.04%
Q4 2018465.9K$20M+1.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Clifford Swan Investment Counsel LLC’s full portfolio or all institutional holders of PFE.